What does the evidence say about Pistachio Blood Lipids Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Pistachio Blood Lipids Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Diets high in free sugars, particularly from sugar-sweetened beverages (SSBs), are associated with abdominal obesity and increased cardiometabolic risk, prompting global guidelines to limit SSBs as a major public health strategy. [Erlich MN (2026); evidence level 2] - Fortified soymilk is a plant-based alternative with approved health claims for cholesterol and coronary heart disease risk reduction that offers an equivalent nutritional value to cow's milk. [Erlich MN (2026); evidence level 2] - The Soy Treatment Evaluation for Metabolic (STEM) health trial seeks to evaluate the impact of replacing SSBs with either 2% soymilk or 2% cow's milk on liver fat and other cardiometabolic risk factors in habitual adult consumers of SSBs with obesity. [Erlich MN (2026); evidence level 2] - Background/Objectives : Liver fat represents an early metabolic lesion in the development of diabetes and its cardiometabolic complications. [Erlich MN (2026); evidence level 2] - A greater capacity for butyrate production is linked to improved postprandial insulin response [] and reductions in glycated hemoglobin (HbA1c) [], suggesting that pistachios may benefit those with impaired glucose metabolism. [Riley Terrence M (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.